Aspirin for primary prevention of cardiovascular events... [JAMA. 2008] - PubMed

Save items

loading

Related citations in PubMed

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. [JAMA. 2008]
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y, Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. JAMA. 2008 Nov 12; 300(18):2134-41. Epub 2008 Nov 9.
Aspirin for primary prevention of cardiovascular events in diabetes. [Diabetes Care. 2003]
Aspirin for primary prevention of cardiovascular events in diabetes.
Colwell JA. Diabetes Care. 2003 Dec; 26(12):3349-50.
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. [Diabetes Care. 2003]
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A, PPP Collaborative Group. Diabetes Care. 2003 Dec; 26(12):3264-72.
Review Aspirin for primary prevention of cardiovascular events in people with diabetes. [J Am Coll Cardiol. 2010]
Review Aspirin for primary prevention of cardiovascular events in people with diabetes.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, et al. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
Review Multifactorial aspects of the treatment of the type II diabetic patient. [Metabolism. 1997]
Review Multifactorial aspects of the treatment of the type II diabetic patient.
Colwell JA. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.

See reviews... See all...

Cited by 3 PubMed Central articles

Review Risk assessment and aspirin use in Asian and Western populations. [Vasc Health Risk Manag. 2010]
Review Risk assessment and aspirin use in Asian and Western populations.
Gao R, Li X. Vasc Health Risk Manag. 2010 Oct 21; 6:943-56. Epub 2010 Oct 21.
Review Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. [BMJ. 2009]
Review Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.
De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A. BMJ. 2009 Nov 6; 339:b4531. Epub 2009 Nov 6.
Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. [Diabetes Care. 2009]
Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.
Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB, Fernandez-Balsells MM, Albuquerque FN, Lampropulos JF, Erwin PJ, et al. Diabetes Care. 2009 Dec; 32(12):2300-6. Epub 2009 Sep 9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Aspirin for primary prevention of cardiovascular events in diabetes: still an op...
Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.
JAMA. 2008 Nov 12 ;300(18):2180-1. Epub 2008 Nov 9 .

PubMed
Expanding the orbit of primary prevention--moving beyond JUPITER.
Expanding the orbit of primary prevention--moving beyond JUPITER.
N Engl J Med. 2008 Nov 20 ;359(21):2280-2. Epub 2008 Nov 9 .

PubMed
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open qu...
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.
Oncologist. 2008 Nov ;13(11):1137-48. Epub 2008 Nov 7 .

PubMed
Exogenous brain-derived neurotrophic factor (BDNF) reverts phenotypic changes in...
Exogenous brain-derived neurotrophic factor (BDNF) reverts phenotypic changes in the retinas of transgenic mice lacking the BDNF gene.
Invest Ophthalmol Vis Sci. 2009 Mar ;50(3):1416-22. Epub 2008 Nov 7 .

PubMed
Crystal structures at 2.2 A resolution of the catalytic domains of normal ras pr...
Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
J Mol Biol. 1991 Feb 5 ;217(3):503-16.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information